Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Ordinary Shares, nominal value of $0.01 per share
-
Shares outstanding
-
2,461,355,158
-
Total 13F shares
-
1,939,037
-
Share change
-
-2,476
-
Total reported value
-
$18,861,000
-
Price per share
-
$9.75
-
Number of holders
-
12
-
Value change
-
-$318,530
-
Number of buys
-
10
-
Number of sells
-
12
Institutional Holders of Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) as of Q4 2021
As of 31 Dec 2021,
Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,939,037 shares.
The largest 10 holders included
COMPASS GROUP LLC, Itau Unibanco Holding S.A., SECTORAL ASSET MANAGEMENT INC, D. E. Shaw & Co., Inc., MORGAN STANLEY, CREDIT SUISSE AG/, GEODE CAPITAL MANAGEMENT, LLC, FNY Investment Advisers, LLC, Penserra Capital Management LLC, and Tower Research Capital LLC (TRC).
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.